Continuous innovation to protect health
INNOVATION NEVER STOPS
Products and Services
Finding solutions for unmet clinical needs, through the entire industry chain of "starting materials → difficult intermediates → characteristic APIs → preparations"
With the goal of "continuous innovation and good health", we have continuously developed and explored for many years, and made breakthroughs in the fields of anti-tumor, anti-infection, immunotherapy, and fatty liver and diabetes treatment.
The production base keeps improving, and guarantees the quality of medicines with internationally high standards of pharmaceutical quality management regulations and strict pharmaceutical production quality management systems.
BrightGene (stock abbreviation: Borui Pharmaceutical; stock code: 688166) is a research and development-driven high-tech pharmaceutical company dedicated to the research and development and production of original new drugs and high-end generic drugs. Product development capabilities and commercialization capabilities to provide patients with products of exceptional value.
With the goal of "continuous innovation and protecting health",
Borui seeks solutions to clinical unmet needs.